TOGETHER WITH OPTIONS TRADING IN 21 DAYS

If the options section ever reads like a foreign language, you're not alone. Investors Love Options is a free 100-page guide from our sister company that walks through it all, written by someone with 22 years as an institutional derivatives trader. Get the free eBook

For those of you who held the DKNG short through earnings, congratulations! It was not a comfortable hold. The stock closed above our $23 line twice in the days before the print, and we stayed in because the whole thesis was the earnings report. Then DraftKings missed on EBITDA, cut its 2026 guide, and gapped from $23.52 to under $17. Short at $20.90, target $17 hit, about 19% on the shares, and the January $20/$17.50 put spread is deep in the money. Every idea we publish, winner or loser, is scored on our Idea Log.

Every week, we cut through the noise and surface opportunities that institutions are already eyeing, but with strategies tailored for retail traders. Today's setup? Russia seized control of a rival tobacco company's local business last week, and investors sold Philip Morris 8.6% in three sessions as if it were next. The business that actually drives this stock is in Japan and in American convenience stores, and it just raised its guide.

We'll cover:

On November 5, a Kremlin decree put the Russian units of Japan Tobacco International under "temporary management" by a state-linked company. A second decree the next day added more JTI units; the owner keeps the title and loses control. Imperial Brands left Russia in 2022 and BAT followed in 2023, which leaves JTI and Philip Morris as the two majors still operating there. The market did the math in one direction: PM closed at $211.28 on November 4 and $193.12 on November 9.

Here is the math the filing actually gives us.

Behind the scenes:

🇷🇺 Russia is real but small: in its 2025 10-K, Philip Morris says Russia was around 6% of net revenues and around 9% of shipment volume. Russian operations held about $4.8 billion of assets, about $2.3 billion of it cash, mostly in rubles.

🔥 The growth is somewhere else: smoke-free products were more than 40% of third-quarter net revenues. In Japan, IQOS holds a 68% share of the heated-tobacco category.

🧃 ZYN is still gaining: U.S. ZYN shipments rose 4.2% to 3.2 billion pouches in Q3, and the company says its category share rose more than 100 basis points from June to September, per Nielsen.

📈 The guide went up, not down: third-quarter net revenues rose 5.5% to $11.4 billion (7.1% organic), adjusted EPS rose 5.4% to $2.36, and full-year adjusted EPS guidance is $8.29 to $8.44, up roughly 10% to 12%.

The research desk we follow has $$PM ( ▼ 0.43% ) as its top long idea and on its Signal Strength long list, and said the Japan Tobacco seizure "has no bearing on the company's numbers." It called the selloff a buying opportunity.

The honest case against: the JTI decree proves the Kremlin will take control of a foreign tobacco business, and Philip Morris is the obvious next one. If it happens, the company could lose control of about 6% of revenue and $4.8 billion of assets. That is a real hit, but it is a one-time write-down on a business guiding to double-digit earnings growth. Hence a hard stop and a defined-risk spread.

Even after the drop, PM is up about 21% this year. Wall Street's average price target sits near $211 (16 analysts, per Investing.com), right where the stock closed before the Russia headline.

The bigger tailwind is the rotation. The research desk we follow is positioned for a slowing economy and cooling inflation and says money is moving into consumer staples; the Consumer Staples ETF (XLP) closed about 1% below its 52-week high while the Nasdaq 100 ETF (QQQ) sits about 11% below its peak. A 3.3% dividend and a raised guide make PM a natural home for that money. Over the same three sessions, Altria (MO), which has no Russian business, fell less than 3%.

PM closed at $211.28 on November 4, then fell three straight sessions to $193.12 on the Russia headline. On Tuesday it closed at $194.25, a hair under its 50-day moving average, and it is holding well above the October 21 low of $184.

Moving Averages:

Key Levels:

The Setup: an uptrend, a headline-driven flush into the 50-day, and no earnings report between here and January. We buy at $195 or better, with a hard line under the October low.

Strengths: more than 40% of revenue from smoke-free products, a 68% heated-tobacco share in Japan, a raised EPS guide and a $6.40 dividend.

Weaknesses: about 6% of revenue and $4.8 billion of assets sit in Russia, and a strong dollar trims reported results.

Opportunities: ZYN share gains in the U.S., IQOS growth, and investors rotating into defensive dividend payers.

Threats: a Kremlin decree aimed at PM itself, Japanese tobacco tax increases slowing IQOS, and FDA or excise surprises on nicotine pouches.

Who should take this: income investors who want a 3.3% yielder on a pullback, and options traders who want a defined-risk way to play a rebound to the pre-headline price.

🟢 Stock Trade

🚀 Options Play: Buy the January 15, 2027 $195/$210 Call Spread

Why this structure: implied volatility is about 27%, and we expect a move back toward $211, not a moonshot, so we sell the $210 call to cut the cost. January 15 is the cleanest expiry: it lands before the fourth-quarter report, which last year came in early February. The March $195/$210 spread costs more and would carry us through that print. (Quotes as of the Nov. 10 close, priced at the ask on the call we buy and the bid on the call we sell; the midpoint is closer to $5.40, so work the order and verify with live brokerage prices.)

How it works: you own the right to buy PM at $195 and have sold someone the right to buy it from you at $210. Every dollar PM climbs between those strikes is yours, and your entire risk is the $590 you pay up front. The spread breaks even at $200.90, just under the 20-day, so a reclaim of that average puts it in the green.

On the shares, a close below $184 is the hard risk line. That is under the October 21 low and just above the 200-day, about 6% from our entry, and it would mean the market is pricing a PM seizure, not just a JTI one. Size at 1% to 2% of your account. On the spread your risk is capped, so buy only what you can afford to lose.

1. Kremlin Headlines - any decree that names Philip Morris is the main risk to this trade. Silence, or JTI control being returned, takes the discount away.

2. The Staples Rotation - as long as money keeps leaving high-beta tech, low-beta dividend payers like PM keep getting bid.

3. ZYN Share Data - Nielsen reads on U.S. nicotine pouches show whether the 100+ basis point gain holds.

4. Next Dividend (ex-date expected late December, not yet declared) - PM pays $1.60 a quarter, and last year's December ex-date fell on December 26.

5. Q4 Earnings and 2027 Guidance (expected early February, date not yet set) - after our option expires; the run-up into it is part of the trade.

Investors Love Options is the free beginner's guide from our sister company, Options Trading in 21 Days: calls and puts, the Greeks, hedging and multi-leg strategies, step by step. Get the free eBook

The Kremlin took control of the other company's Russian business, and the market sold Philip Morris as if it had been taken.

$$PM ( ▼ 0.43% ) gets about 6% of its revenue from Russia and most of its growth from IQOS in Japan and ZYN in America. It raised its guide last month, pays a 3.3% dividend, and has pulled back to its 50-day moving average on a headline that did not touch its numbers.

If it closes below $184, the market is pricing a seizure and we step aside. If it does not, the 20-day is the first stop and $211 is the target.

✅ Buy PM at $195 or better

💸 Buy the Jan. 15, 2027 $195/$210 call spread for a $5.90 net debit

Every idea we publish is scored, win or lose, on our Idea Log. The way we build each setup is explained on our options trade ideas page.

Want more trade ideas like this - plus weekly options plays and breakdowns?

👉 Join the Paid Resilient Trader Newsletter

For more in-depth trading strategies and market insights, upgrade to the paid version of our newsletter.

Our paid newsletter gives you:

Stay Liquid, my friends

- The Resilient Trader

Disclaimer: This publication is for educational purposes only and is not investment advice. Options involve risk and are not suitable for all investors. Do your own research and consider consulting a licensed financial professional.

💌 P.S. Want this in your inbox every week?

Subscribe to the Resilient Trader Free Newsletter